NewsPR Newswire
INOVIO Announces Favorable Judgment in Litigation with VGXI, Inc. and GeneOne Life Science
· Published
Article summary
INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced...
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…